TMO

TMO Accumulated OCI

-$2.46BQuarterly · USD

Period ending:

TMO FY Accumulated OCIUSD
TMO FY Accumulated OCI1985-12-31: $0.001986-12-31: $0.001987-12-31: $0.001988-12-31: $0.001989-12-31: $0.001990-12-31: $0.001991-12-31: $0.001992-12-31: $0.001993-12-31: $0.001994-12-31: -$179.20M1995-12-31: $2.00M1996-12-31: $16.00M1997-12-31: -$72.00M1998-12-31: -$36.00M1999-12-31: -$116.00M2000-12-31: -$103.00M2001-12-31: -$204.00M2002-12-31: -$38.51M2003-12-31: $81.49M2004-12-31: $158.81M2005-12-31: $23.35M2006-12-31: $150.16M2007-12-31: $388.40M2008-12-31: -$145.80M2009-12-31: $92.00M2010-12-31: $43.60M2011-12-31: -$399.50M2012-12-31: -$150.40M2013-12-31: -$77.20M2014-12-31: -$1.29B2015-12-31: -$2.00B2016-12-31: -$2.64B2017-12-31: -$2.00B2018-12-31: -$2.50B2019-12-31: -$2.68B2020-12-31: -$2.81B2021-12-31: -$2.33B2022-12-31: -$3.10B2023-12-31: -$3.22B2024-12-31: -$2.70B2025-12-31: -$2.45B$388.40M-$3.22B
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TMO accumulated oci history

Accumulated other comprehensive income (loss). The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Thermo Fisher Scientific Accumulated OCI — Annual fiscal periods (USD)
Period endingAccumulated OCI (USD)
-2,448,000,000
-2,697,000,000
-3,224,000,000
-3,099,000,000
-2,329,000,000
-2,807,000,000
-2,679,000,000
-2,498,000,000
-2,003,000,000
-2,636,300,000
-1,997,300,000
-1,285,000,000
-77,200,000
-150,399,999
-399,500,000
43,600,000
92,000,000
-145,800,000
388,400,000
150,158,000
23,345,000
158,805,000
81,494,000
-38,510,000
-204,000,000
-103,000,000
-116,000,000
-36,000,000
-72,000,000
16,000,000
2,000,000
-179,200,000
0
0
0
0
0
0
0
0
0

Compare accumulated oci

All TMO financial metrics · TMO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.